• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

Genotyping of Multi Drug Resistant Tuberculosis Among the Smear Positive Pulmonary Tuberculosis Cases at a Tertiary Care Hospital

    Dr. Gudesh Kumar, Dr. Sanjeev Kumar, Dr. Manish Kumar, Dr. Rakesh Kumar, Dr. Namrata Kumari

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 11242-11248

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background:Mycobacterium tuberculosis was discovered by Robert Koch on March 24, 1882, and every year this day is remembered as the World Tuberculosis (TB) Day.
Objectives: To detect MDR-TB among new cases of smear positive pulmonary tuberculosis by Genotyping method.
Materials and methods: Prospective study was conducted in patients with sputum-positive pulmonary tuberculosis to detect resistance to Rifampicin and Isoniazid using Genotyping by Hain’s technique at RNTCP in IGIMS, Patna , Bihar. 78 patients were study duration of eighteen months. The data was collected after obtaining permission from Institutional Ethical Committee,
Conclusion: LPA- Hain’s technique identifies sensitivity to Rifampicin and Isoniazid in the clinical isolates and provides results in 2-3 days which in turn helps the patient to initiate early treatment and community at large to prevent the spread of MDR-TB.
Keywords:
  • PDF (180 K)
  • XML
(2022). Genotyping of Multi Drug Resistant Tuberculosis Among the Smear Positive Pulmonary Tuberculosis Cases at a Tertiary Care Hospital. European Journal of Molecular & Clinical Medicine, 9(3), 11242-11248.
Dr. Gudesh Kumar, Dr. Sanjeev Kumar, Dr. Manish Kumar, Dr. Rakesh Kumar, Dr. Namrata Kumari. "Genotyping of Multi Drug Resistant Tuberculosis Among the Smear Positive Pulmonary Tuberculosis Cases at a Tertiary Care Hospital". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 11242-11248.
(2022). 'Genotyping of Multi Drug Resistant Tuberculosis Among the Smear Positive Pulmonary Tuberculosis Cases at a Tertiary Care Hospital', European Journal of Molecular & Clinical Medicine, 9(3), pp. 11242-11248.
Genotyping of Multi Drug Resistant Tuberculosis Among the Smear Positive Pulmonary Tuberculosis Cases at a Tertiary Care Hospital. European Journal of Molecular & Clinical Medicine, 2022; 9(3): 11242-11248.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 48
  • PDF Download: 89
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus